1 6

Cited 0 times in

Cited 0 times in

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines

DC Field Value Language
dc.contributor.authorLee, Banghyun-
dc.contributor.authorChang, Suk-Joon-
dc.contributor.authorKwon, Byung Su-
dc.contributor.authorSon, Joo-Hyuk-
dc.contributor.authorLim, Myong Cheol-
dc.contributor.authorKim, Yun Hwan-
dc.contributor.authorLee, Shin-Wha-
dc.contributor.authorChoi, Chel Hun-
dc.contributor.authorEoh, Kyung Jin-
dc.contributor.authorLee, Jung-Yun-
dc.contributor.authorLee, Yoo-Young-
dc.contributor.authorSuh, Dong Hoon-
dc.contributor.authorKim, Yong Beom-
dc.date.accessioned2025-11-18T01:56:03Z-
dc.date.available2025-11-18T01:56:03Z-
dc.date.created2025-07-16-
dc.date.issued2025-01-
dc.identifier.issn2005-0380-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208935-
dc.description.abstractWe updated the Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of ovarian cancer as version 5.1. The ovarian cancer guideline team of the KSGO published announced the fifth version (version 5.0) of its clinical practice guidelines for the management of ovarian cancer in December 2023. Inversion 5.0, the selection of the key questions and the systematic reviews were based on the data available up to December 2022. Therefore, we updated the guidelines version 5.0 with newly accumulated clinical data and added 5 new key questions reflecting the latest insights in the field of ovarian cancer between 2023 and 2024. For each question, recommendation was provided together with corresponding level of evidence and grade ofrecommendation, all established through expert consensus.-
dc.languageEnglish-
dc.publisherAsian Society of Gynecologic Oncology : Taehan Puin Chongyang Hakhoe-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.subject.MESHCarcinoma, Ovarian Epithelial* / therapy-
dc.subject.MESHFemale-
dc.subject.MESHGynecology / standards-
dc.subject.MESHHumans-
dc.subject.MESHMedical Oncology / standards-
dc.subject.MESHOvarian Neoplasms* / diagnosis-
dc.subject.MESHOvarian Neoplasms* / therapy-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHSocieties, Medical-
dc.titleClinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines-
dc.typeArticle-
dc.contributor.googleauthorLee, Banghyun-
dc.contributor.googleauthorChang, Suk-Joon-
dc.contributor.googleauthorKwon, Byung Su-
dc.contributor.googleauthorSon, Joo-Hyuk-
dc.contributor.googleauthorLim, Myong Cheol-
dc.contributor.googleauthorKim, Yun Hwan-
dc.contributor.googleauthorLee, Shin-Wha-
dc.contributor.googleauthorChoi, Chel Hun-
dc.contributor.googleauthorEoh, Kyung Jin-
dc.contributor.googleauthorLee, Jung-Yun-
dc.contributor.googleauthorLee, Yoo-Young-
dc.contributor.googleauthorSuh, Dong Hoon-
dc.contributor.googleauthorKim, Yong Beom-
dc.identifier.doi10.3802/jgo.2025.36.e69-
dc.relation.journalcodeJ01428-
dc.identifier.eissn2005-0399-
dc.identifier.pmid39900344-
dc.subject.keywordHyperthermic Intraperitoneal Chemotherapy-
dc.subject.keywordRisk-educing Salpingo-oophorectomy-
dc.subject.keywordPoly(ADP-ribose) Polymerase (PARP) Inhibitor-
dc.subject.keywordMirvetuximab Soravtansine-
dc.subject.keywordTrastuzumab Deruxtecan-
dc.subject.keywordPractice Guideline-
dc.subject.keywordOvarian Neoplasms-
dc.contributor.affiliatedAuthorEoh, Kyung Jin-
dc.contributor.affiliatedAuthorLee, Jung-Yun-
dc.identifier.scopusid2-s2.0-85217159053-
dc.identifier.wosid001411526300010-
dc.citation.volume36-
dc.citation.number1-
dc.identifier.bibliographicCitationJOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.36(1), 2025-01-
dc.identifier.rimsid87951-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorHyperthermic Intraperitoneal Chemotherapy-
dc.subject.keywordAuthorRisk-educing Salpingo-oophorectomy-
dc.subject.keywordAuthorPoly(ADP-ribose) Polymerase (PARP) Inhibitor-
dc.subject.keywordAuthorMirvetuximab Soravtansine-
dc.subject.keywordAuthorTrastuzumab Deruxtecan-
dc.subject.keywordAuthorPractice Guideline-
dc.subject.keywordAuthorOvarian Neoplasms-
dc.subject.keywordPlusCHEMOTHERAPY-
dc.type.docTypeArticle-
dc.identifier.kciidART003169676-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalWebOfScienceCategoryObstetrics & Gynecology-
dc.relation.journalResearchAreaOncology-
dc.relation.journalResearchAreaObstetrics & Gynecology-
dc.identifier.articlenoe69-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.